Current Ratio in % of MiNK Therapeutics, Inc. from Q2 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
MiNK Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2022 to Q3 2025.
  • MiNK Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2025 was 55 %, a 14.1% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)

MiNK Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 55 -9.04 -14.1% Sep 30, 2025
Q2 2025 43.3 -16.1 -27.1% Jun 30, 2025
Q1 2025 67.2 +6.08 +9.95% Mar 31, 2025
Q4 2024 75.9 -6.41 -7.79% Dec 31, 2024
Q3 2024 64 -52.7 -45.1% Sep 30, 2024
Q2 2024 59.3 -73.4 -55.3% Jun 30, 2024
Q1 2024 61.1 -90.6 -59.7% Mar 31, 2024
Q4 2023 82.3 -81.9 -49.9% Dec 31, 2023
Q3 2023 117 -65.8 -36% Sep 30, 2023
Q2 2023 133 +51 +62.4% Jun 30, 2023
Q1 2023 152 Mar 31, 2023
Q4 2022 164 Dec 31, 2022
Q3 2022 183 Sep 30, 2022
Q2 2022 81.7 Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.